KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $3.9 billion.

  • Charles River Laboratories International's Total Non-Current Liabilities fell 167.34% to $3.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 billion, marking a year-over-year decrease of 167.34%. This contributed to the annual value of $3.8 billion for FY2024, which is 1130.95% down from last year.
  • Per Charles River Laboratories International's latest filing, its Total Non-Current Liabilities stood at $3.9 billion for Q3 2025, which was down 167.34% from $4.0 billion recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Total Non-Current Liabilities registered a high of $4.6 billion during Q2 2022, and its lowest value of $3.4 billion during Q1 2021.
  • Its 5-year average for Total Non-Current Liabilities is $4.1 billion, with a median of $4.2 billion in 2022.
  • Per our database at Business Quant, Charles River Laboratories International's Total Non-Current Liabilities soared by 4108.74% in 2021 and then plummeted by 1130.95% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Total Non-Current Liabilities (Quarter) stood at $4.2 billion in 2021, then increased by 5.13% to $4.4 billion in 2022, then dropped by 2.08% to $4.3 billion in 2023, then decreased by 11.31% to $3.8 billion in 2024, then grew by 1.27% to $3.9 billion in 2025.
  • Its Total Non-Current Liabilities stands at $3.9 billion for Q3 2025, versus $4.0 billion for Q2 2025 and $4.1 billion for Q1 2025.